Tirzepatide is a dual-agonist research peptide being studied for its interactions with GIP and GLP-1 receptor pathways.

Researchers investigate its effects on metabolic signalling, appetite-related pathways, and glucose–insulin mechanisms.

This compound is supplied strictly for laboratory research and is not intended for human consumption or therapeutic use.